Page 29 - Nathalie Altermatt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate |F Hoffmann-La Roche Ltd Announcements | F Hoffmann-La Roche Ltd: FDA approves Roche s Lunsumio, a first-in-class bispecific antibody, to treat people with relapsed or refractory follicular lymphoma

Investegate announcements from F. Hoffmann-La Roche Ltd, FDA approves Roche’s Lunsumio, a first-in-class bispecific antibody, to treat people with relapsed or refractory follicular lymphoma

United statesRoche lunsumioLevi garrawayLoren kalmElizabeth buddeNathalie altermattNational cancer instituteWorld health organizationDrug administrationHealth professional versionHead of global product developmentDepartment of hematology hematopoietic cell transplantationCity of hope division lymphomaRoche groupRoche group media relationsHaematologic oncologist

F Hoffmann-La Roche Ltd: FDA approves Roche s Actemra for the treatment of COVID-19 in hospitalised adults

Actemra is the first FDA-approved monoclonal antibody to treat COVID-19 Since the beginning of the pandemic, more than one million people hospitalised with COVID-19 have been treated with Actemra worldwide

United statesNew zealandUnited kingdomLevi garrawayActemra roactemraNathalie altermattWorld health organizationDrug administrationHead of global product developmentEuropean unionRoche groupRoche group media relationsChief medical officerGlobal productUse authorizationWorld health

FDA approves Roche s Actemra for the treatment of COVID-19 in hospitalised adults

FDA approves Roche s Actemra for the treatment of COVID-19 in hospitalised adults
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew zealandUnited kingdomLevi garrawayActemra roactemraNathalie altermattWorld health organizationDrug administrationHead of global product developmentEuropean unionRoche groupRoche group media relationsChief medical officerGlobal productUse authorizationWorld health

Investegate |F Hoffmann-La Roche Ltd Announcements | F Hoffmann-La Roche Ltd: FDA approves Roche s Actemra for the treatment of COVID-19 in hospitalised adults

Investegate announcements from F. Hoffmann-La Roche Ltd, FDA approves Roche’s Actemra for the treatment of COVID-19 in hospitalised adults

United statesNew zealandUnited kingdomRoche actemraLevi garrawayActemra roactemraNathalie altermattWorld health organizationDrug administrationHead of global product developmentEuropean unionRoche groupRoche group media relationsChief medical officerGlobal productUse authorization

F Hoffmann-La Roche Ltd: Roche presents new and updated data for Polivy in previously untreated diffuse large B-cell lymphoma at ASH 2022

Updated data from the phase III POLARIX study continue to demonstrate a statistically significant reduction in the risk of disease worsening or death for people with previously untreated diffuse large

United statesLevi garrawayMabthera rituxanGazyva gazyvaroSabine borngrGerard tobinBruno eschliVenclexta venclyxtoBirgit masjostLoren kalmNathalie altermattAmerican society of hematologyDrug administrationRoche groupHead of global product developmentRoche group media relations